Cargando…
Acquired lymphedema: Molecular contributors and future directions for developing intervention strategies
Lymphedema is a debilitating chronic disease that mostly develops as an adverse reaction to cancer treatment modalities such as chemotherapy, surgery, and radiotherapy. Lymphedema also appears to be a deteriorating consequence of roundworm infections, as best represented by filariasis. According to...
Autores principales: | Nurlaila, Ika, Roh, Kangsan, Yeom, Chang-Hwan, Kang, Hee, Lee, Sukchan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9640931/ https://www.ncbi.nlm.nih.gov/pubmed/36386144 http://dx.doi.org/10.3389/fphar.2022.873650 |
Ejemplares similares
-
Oxaliplatin-Induced Peripheral Neuropathy via TRPA1 Stimulation in Mice Dorsal Root Ganglion Is Correlated with Aluminum Accumulation
por: Park, Jin-Hee, et al.
Publicado: (2015) -
Pharmacological Treatment of Secondary Lymphedema
por: Brown, Stav, et al.
Publicado: (2022) -
Current Evidence and Future Directions of Berberine Intervention in Depression
por: Zhu, Wen-Qian, et al.
Publicado: (2022) -
Hypoxia and Hypoxia-Inducible Factors in Lymphedema
por: Jiang, Xinguo, et al.
Publicado: (2022) -
Doxycycline for the treatment of breast cancer-related lymphedema
por: Brown, Stav, et al.
Publicado: (2022)